90-90-90
An Ambitious treatment target to
help end the AIDS epidemic
Nancy Somi
What's 90-90-90?
A new HIV treatment narrative that lays the ground works to end the AIDS epidemic
• By 2020, 90% of all people living with HIV will know their HIV status.
• By 2020, 90% of all people with diagnosed HIV infection will receive sustained
antiretroviral therapy
• By 2020, 90% of all people receiving antiretroviral therapy will have viral suppression.
The target was initiated by UNAIDS under WHO.
Why the 90-90-90 Target
• Target will drive progress. Until December 2013 more than 60% of people
living with HIV lacked HIV treatment underscoring the need for intensified
efforts to bring HIV treatment to all those who need it
• Target guides action taken beyond 2015-Ending AIDS will require new
milestones to guide and accelerate progress in the post 2015 era
• Target promotes accountability-A clearly articulated goal enables diverse
stakeholders to identify respective roles and responsibilities.
• A bold Target undescores that ending AIDS epidemic is achievable-
Boldly grasping this challenge ensures that ending AIDS epidemic in the
world is possible by 2030.
How will 90-90-90 succeed
• Focus on the new quality and outcomes of antiretroviral therapy as
treatment services are scaled up.
• The new target captures both the therapeutic and preventive benefits of
HIV treatment.
• It prioritizes equity- Unless all communities affected by HIV have full and
equitable access to life saving treatment and other prevention services the
world will not end the AIDS epidemic.
First 90:90% diagnosed
• African countries are either approaching or within the striking distance of
having at least 90% of people living with HIV/AIDS tested at least.
• Until December 2013 only 45% of people living with HIV knew their status
in sub-Saharan Africa.
• The gap underscores a need for more frequent testing.
• Testing in multi disease health campaigns in Kenya and Uganda increased the
testing coverage to 86% and 72%.
Second 90:90% on HIV treatment.
• High treatment coverage is also achieved in some settings e.g. in Botswana
and Colombia more than 70% of people diagnosed with HIV are now
receiving antiretroviral therapy.
• Recomending antiretroviral therapy to all people with HIV infection without
requiring prior CD4 count will enhance treatment and reduce loss to follow
up.
• Countries will need to implement issues that slow up implemtation like;
pharmacy stock outs, procurement of medicnes and second and third line
regimens.
Last 90:90%Viral Suppressed
• High levels of viral suppression have been achieved in some countries e.g 17
countries in Latin America and Carribean countries have 66% of those
diagnosed are viral suppressed.
• Viral suppression doesn’t count for AIDS related mortality or loss to follow
up highlighting efforts to retain those who are loss to follow among the ones
enrolled in care.
• Viral load testing will lower treatment costs and help clinicians identify early
treatment failure.
Last 90 contd…..
• Ensuring universal access to viral load testing in all settings is vital.
• UNAIDS,WHO, ASLM and US CDC jointly convened the role of
laboratory medicine in meeting the 90-90-90 targets in June 2014
• The meeting was aimed at building robust, sustainability laboratory capacity
that will be needed to meet the global treatment goals
Challenges along the road!
• Societal Challenges- Stigma, discrimination
• Delivery Challenges-Centralization of treatment centers reduces success of
treatment. Strategies should be tailored by stakeholders to make sure even
those in remote areas can access HIV treatment.
• Costs of achieving the 90-90-90 target-Increased funding will be needed to
end the AIDS epidemic.Costs are incured in drugs,delivery service,laboratory
capacity and community mobilization to ensure testing and retention in care.
90 90-90

90 90-90

  • 1.
    90-90-90 An Ambitious treatmenttarget to help end the AIDS epidemic Nancy Somi
  • 2.
    What's 90-90-90? A newHIV treatment narrative that lays the ground works to end the AIDS epidemic • By 2020, 90% of all people living with HIV will know their HIV status. • By 2020, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy • By 2020, 90% of all people receiving antiretroviral therapy will have viral suppression. The target was initiated by UNAIDS under WHO.
  • 4.
    Why the 90-90-90Target • Target will drive progress. Until December 2013 more than 60% of people living with HIV lacked HIV treatment underscoring the need for intensified efforts to bring HIV treatment to all those who need it • Target guides action taken beyond 2015-Ending AIDS will require new milestones to guide and accelerate progress in the post 2015 era • Target promotes accountability-A clearly articulated goal enables diverse stakeholders to identify respective roles and responsibilities. • A bold Target undescores that ending AIDS epidemic is achievable- Boldly grasping this challenge ensures that ending AIDS epidemic in the world is possible by 2030.
  • 5.
    How will 90-90-90succeed • Focus on the new quality and outcomes of antiretroviral therapy as treatment services are scaled up. • The new target captures both the therapeutic and preventive benefits of HIV treatment. • It prioritizes equity- Unless all communities affected by HIV have full and equitable access to life saving treatment and other prevention services the world will not end the AIDS epidemic.
  • 6.
    First 90:90% diagnosed •African countries are either approaching or within the striking distance of having at least 90% of people living with HIV/AIDS tested at least. • Until December 2013 only 45% of people living with HIV knew their status in sub-Saharan Africa. • The gap underscores a need for more frequent testing. • Testing in multi disease health campaigns in Kenya and Uganda increased the testing coverage to 86% and 72%.
  • 7.
    Second 90:90% onHIV treatment. • High treatment coverage is also achieved in some settings e.g. in Botswana and Colombia more than 70% of people diagnosed with HIV are now receiving antiretroviral therapy. • Recomending antiretroviral therapy to all people with HIV infection without requiring prior CD4 count will enhance treatment and reduce loss to follow up. • Countries will need to implement issues that slow up implemtation like; pharmacy stock outs, procurement of medicnes and second and third line regimens.
  • 8.
    Last 90:90%Viral Suppressed •High levels of viral suppression have been achieved in some countries e.g 17 countries in Latin America and Carribean countries have 66% of those diagnosed are viral suppressed. • Viral suppression doesn’t count for AIDS related mortality or loss to follow up highlighting efforts to retain those who are loss to follow among the ones enrolled in care. • Viral load testing will lower treatment costs and help clinicians identify early treatment failure.
  • 9.
    Last 90 contd….. •Ensuring universal access to viral load testing in all settings is vital. • UNAIDS,WHO, ASLM and US CDC jointly convened the role of laboratory medicine in meeting the 90-90-90 targets in June 2014 • The meeting was aimed at building robust, sustainability laboratory capacity that will be needed to meet the global treatment goals
  • 11.
    Challenges along theroad! • Societal Challenges- Stigma, discrimination • Delivery Challenges-Centralization of treatment centers reduces success of treatment. Strategies should be tailored by stakeholders to make sure even those in remote areas can access HIV treatment. • Costs of achieving the 90-90-90 target-Increased funding will be needed to end the AIDS epidemic.Costs are incured in drugs,delivery service,laboratory capacity and community mobilization to ensure testing and retention in care.